• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床显微镜检查实验室与细胞病理学实验室在体液中恶性细胞检测方面的比较。

Comparison of the clinic microscopy laboratory with the cytopathology laboratory in the detection of malignant cells in body fluids.

作者信息

Ben-Ezra J, Stastny J F, Harris A C, Bork L, Frable W J

机构信息

Department of Pathology, Medical College of Virginia, Richmond 23298.

出版信息

Am J Clin Pathol. 1994 Oct;102(4):439-42. doi: 10.1093/ajcp/102.4.439.

DOI:10.1093/ajcp/102.4.439
PMID:7942600
Abstract

The clinical microscopy (fluids) laboratory evaluates almost every body fluid that is obtained in the hospital. Because the fluids laboratory functions at all hours, it is often the first laboratory to receive a body fluid. In addition to its primary purpose of quantitating categories of cells, the medical technologist in this laboratory has an opportunity to identify malignant cells. To our knowledge, no formal study has ever been undertaken to evaluate the performance of the fluids laboratory in detecting malignancy. The authors therefore retrospectively identified 928 body fluids (pleural, peritoneal, cerebrospinal, and miscellaneous) over a 2-year period that had undergone simultaneous cytologic examination in our cytopathology laboratory and body fluid analysis in our fluids laboratory. Of these, a cytologic diagnosis of malignancy was made by the cytopathology laboratory in 107 cases; 821 were considered to be benign. No false-positive results were rendered by the fluids laboratory (100% specificity), but only 26 of the 107 malignant cases were identified (24% sensitivity); the overall accuracy was 93%. Factors contributing to the inability of the fluids laboratory to identify malignant cells included (1) too few cells to warrant a cytocentrifuge preparation, especially in cerebrospinal fluid specimens; (2) differences in the processing of specimens; (3) differences in staining procedures; and (4) differences in the training of personnel. The authors conclude that although the fluids laboratory correctly identifies neoplastic cells in approximately one fourth of the cases in which they are present, it should not be expected to detect malignant cells in every cytologically malignant case.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

临床显微镜检查(体液)实验室几乎对医院获取的每一种体液进行评估。由于体液实验室随时都在运作,它往往是第一个接收体液的实验室。除了对细胞类别进行定量的主要目的外,该实验室的医学技术人员还有机会识别恶性细胞。据我们所知,尚未进行过正式研究来评估体液实验室在检测恶性肿瘤方面的表现。因此,作者回顾性地确定了在两年时间内的928份体液(胸腔、腹腔、脑脊液和其他),这些体液在我们的细胞病理学实验室同时进行了细胞学检查,并在我们的体液实验室进行了体液分析。其中,细胞病理学实验室对107例做出了恶性细胞学诊断;821例被认为是良性的。体液实验室没有给出假阳性结果(特异性为100%),但在107例恶性病例中仅识别出26例(敏感性为24%);总体准确率为93%。导致体液实验室无法识别恶性细胞的因素包括:(1)细胞数量过少,不足以进行细胞离心涂片制备,尤其是在脑脊液标本中;(2)标本处理方式的差异;(3)染色程序的差异;(4)人员培训的差异。作者得出结论,尽管体液实验室在大约四分之一存在肿瘤细胞的病例中能够正确识别肿瘤细胞,但不应期望它在每一例细胞学诊断为恶性的病例中都能检测到恶性细胞。(摘要截短为250字)

相似文献

1
Comparison of the clinic microscopy laboratory with the cytopathology laboratory in the detection of malignant cells in body fluids.临床显微镜检查实验室与细胞病理学实验室在体液中恶性细胞检测方面的比较。
Am J Clin Pathol. 1994 Oct;102(4):439-42. doi: 10.1093/ajcp/102.4.439.
2
A comparison of the effectiveness of malignancy detection in body fluid examination by the cytopathology and hematology laboratories.细胞病理学实验室与血液学实验室在体液检查中恶性肿瘤检测有效性的比较。
Arch Pathol Lab Med. 1997 Sep;121(9):976-9.
3
Detection of malignancy in body fluids: a comparison of the hematology and cytology laboratories.体液中的恶性肿瘤检测:血液学和细胞学实验室的比较。
Arch Pathol Lab Med. 2014 May;138(5):651-7. doi: 10.5858/arpa.2013-0295-OA.
4
Correlation between the papanicolaou stain and the Wright-Giemsa stain in body fluids: a quality assurance study.体液中巴氏染色法与瑞氏-吉姆萨染色法的相关性:一项质量保证研究。
Anal Quant Cytol Histol. 2006 Jun;28(3):171-4.
5
Detection of the human telomerase RNA component by in situ hybridization in cells from body fluids.通过原位杂交检测体液细胞中的人端粒酶RNA组分。
Acta Cytol. 2005 Jan-Feb;49(1):31-7. doi: 10.1159/000326092.
6
Comparison of the clinical microscopy laboratory with the cytopathology laboratory in the detection of malignant cells in body fluids.临床显微镜检查实验室与细胞病理学实验室在检测体液中恶性细胞方面的比较。
Am J Clin Pathol. 1995 Apr;103(4):533. doi: 10.1093/ajcp/103.4.533.
7
p53 immunostaining as a marker of malignancy in cytologic preparations of body fluids.p53免疫染色作为体液细胞涂片检查中恶性肿瘤的标志物
Acta Cytol. 1995 Mar-Apr;39(2):171-6.
8
Body fluid microscopy in US laboratories. Data from two College of American Pathologists surveys, with practice recommendations.美国实验室中的体液显微镜检查。来自美国病理学家学会两项调查的数据及实践建议。
Arch Pathol Lab Med. 1994 Jan;118(1):13-7.
9
Significance of psammoma bodies in serous cavity fluid: a cytopathologic analysis.砂粒体在浆膜腔液中的意义:细胞病理学分析
Cancer. 2004 Apr 25;102(2):87-91. doi: 10.1002/cncr.20161.
10
Improving Malignancy Detection Rates in Body Fluids Submitted to the Hematology Laboratory for Nucleated Cell Count and Differential: A Quality Improvement Study.提高血液学实验室提交的有核细胞计数和分类体液标本中恶性肿瘤的检出率:一项质量改进研究。
Arch Pathol Lab Med. 2021 Feb 1;145(2):201-207. doi: 10.5858/arpa.2019-0617-OA.

引用本文的文献

1
Novel flowcytometry-based approach of malignant cell detection in body fluids using an automated hematology analyzer.一种基于新型流式细胞术的方法,利用自动血液分析仪检测体液中的恶性细胞。
PLoS One. 2018 Feb 9;13(2):e0190886. doi: 10.1371/journal.pone.0190886. eCollection 2018.